アルツハイマー病治療薬・診断薬の世界市場:販売動向2018

【英語タイトル】Global Alzheimer's Disease Therapeutics and Diagnostics Sales Market Report 2018

QYResearchが出版した調査資料(QYR80700722)・商品コード:QYR80700722
・発行会社(調査会社):QYResearch
・発行日:2018年10月
・ページ数:111
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、世界主要国(日本、アメリカ、中国、ヨーロッパ等)
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、アルツハイマー病治療薬・診断薬の世界市場について調査・分析し、アルツハイマー病治療薬・診断薬のメーカー別販売量、市場シェア分析、種類別販売分析(バイオマーカー、コリンエステラーゼ阻害剤、NMDA受容体アンタゴニスト、脳イメージング、血液検査)、用途別販売分析(薬市場、診断薬市場)、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、アルツハイマー病治療薬・診断薬産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・アルツハイマー病治療薬・診断薬市場概要
・アルツハイマー病治療薬・診断薬のメーカー別販売量・メーカー別シェア
・アルツハイマー病治療薬・診断薬の世界市場:種類別販売量(バイオマーカー、コリンエステラーゼ阻害剤、NMDA受容体アンタゴニスト、脳イメージング、血液検査)
・アルツハイマー病治療薬・診断薬の世界市場:用途別販売量(薬市場、診断薬市場)
・アルツハイマー病治療薬・診断薬の世界市場:地域別販売量・市場シェア
・アルツハイマー病治療薬・診断薬の米国市場規模
・アルツハイマー病治療薬・診断薬の中国市場規模
・アルツハイマー病治療薬・診断薬の欧州市場規模
・アルツハイマー病治療薬・診断薬の日本市場規模
・アルツハイマー病治療薬・診断薬の東南アジア市場規模
・アルツハイマー病治療薬・診断薬のインド市場規模
・アルツハイマー病治療薬・診断薬のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・アルツハイマー病治療薬・診断薬のコスト分析・価格動向
・アルツハイマー病治療薬・診断薬の産業チェーン(サプライチェーン分析)
・アルツハイマー病治療薬・診断薬のマーケティング戦略・販売チャネル、流通業者
・アルツハイマー病治療薬・診断薬市場への影響要因分析
・アルツハイマー病治療薬・診断薬の世界市場予測
・アルツハイマー病治療薬・診断薬の米国市場予測
・アルツハイマー病治療薬・診断薬の中国市場予測
・アルツハイマー病治療薬・診断薬の欧州市場予測
・アルツハイマー病治療薬・診断薬の日本市場予測
・アルツハイマー病治療薬・診断薬の東南アジア市場予測
・アルツハイマー病治療薬・診断薬のインド市場予測
・アルツハイマー病治療薬・診断薬の種類別世界市場予測(バイオマーカー、コリンエステラーゼ阻害剤、NMDA受容体アンタゴニスト、脳イメージング、血液検査)
・アルツハイマー病治療薬・診断薬の用途別世界市場予測(薬市場、診断薬市場)
...
【レポートの概要】

This report studies the global Alzheimer’s Disease Therapeutics and Diagnostics market status and forecast, categorizes the global Alzheimer’s Disease Therapeutics and Diagnostics market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Alzheimer’s disease (AD) is the most common reason of progressive dementia in the elderly population. There has been an exponential rise in the number of cases of Alzheimer’s disease worldwide emphasizing the necessity for developing an effective treatment. According to Alzheimer’s Association, in 2016, an estimated 5.4 million Americans of all ages have Alzheimer’s disease. One in nine people aged 65 and above has Alzheimer’s disease. By 2050, the number of people aged 65 and above affected with Alzheimer’s disease is expected to nearly triple, from 5.2 million to an expected 13.8 million, excluding the development of medical advances to avert or cure the disease. The mortality rates due to Alzheimer’s disease are quite high. Between 2000 and 2013, deaths due to heart disease, stroke and prostate cancer decreased 14%, 23% and 11%, respectively, while deaths from AD increased 71% in the U.S. Similarly, According to Alzheimer’s disease International in 2015, there are an estimated 46.8 million people worldwide living with dementia and is further expected to grow in future. Thus, there is an increasing in the demand for Alzheimer’s therapeutics and diagnostics worldwide.

Population aging across the globe is a major factor driving the market for Alzheimer’s therapeutics and diagnostics. Rising life expectancy is contributing to quick increases in number of aged population, and is associated with increased prevalence of chronic diseases like dementia. Therapies for AD offer temporary and uncertain improvements in the well-being of individuals, and none of the approved drugs can modify the course of the disease advancement. Thus, the magnitude of the affected population and lack of suitable and effective treatment offers an incredible opportunity for drug manufacturers. However, identification of the primary reasons and mechanisms involved in AD are is limited. Drug manufacturers have been unable to validate significant clinical benefits of treatment for a numerous of new compounds due to strict regulations. One of the significant trend observed in this market is collaboration of the existing players. Precisely, diagnostic technology companies are carefully trying to bring about effective biomarker technologies to support and improve the drug development process for potential drug candidates which is further expected to propel the demand.
The global Alzheimer’s Disease Therapeutics and Diagnostics market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major players covered in this report
Namenda
Aricept
Exelon
Solanezumab
Gantenerumab
Verubecestat
Pfizer
Eisai
Actavis
Lundbeck
Daiichi Sankyo
Novartis
TauRx

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Biomarkers
Cholinesterase inhibitors
NMDA receptor antagonists
Brain imaging
Blood tests
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Drugs Market
Diagnostics Market

The study objectives of this report are:
To analyze and study the global Alzheimer’s Disease Therapeutics and Diagnostics sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Alzheimer’s Disease Therapeutics and Diagnostics players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Alzheimer’s Disease Therapeutics and Diagnostics are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Alzheimer’s Disease Therapeutics and Diagnostics Manufacturers
Alzheimer’s Disease Therapeutics and Diagnostics Distributors/Traders/Wholesalers
Alzheimer’s Disease Therapeutics and Diagnostics Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Alzheimer’s Disease Therapeutics and Diagnostics market, by end-use.
Detailed analysis and profiles of additional market players.

【レポートの目次】

Table of Contents

Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Market Report 2018
1 Alzheimer’s Disease Therapeutics and Diagnostics Market Overview
1.1 Product Overview and Scope of Alzheimer’s Disease Therapeutics and Diagnostics
1.2 Classification of Alzheimer’s Disease Therapeutics and Diagnostics by Product Category
1.2.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Biomarkers
1.2.4 Cholinesterase inhibitors
1.2.5 NMDA receptor antagonists
1.2.6 Brain imaging
1.2.7 Blood tests
1.3 Global Alzheimer’s Disease Therapeutics and Diagnostics Market by Application/End Users
1.3.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Drugs Market
1.3.2 Diagnostics Market
1.4 Global Alzheimer’s Disease Therapeutics and Diagnostics Market by Region
1.4.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Alzheimer’s Disease Therapeutics and Diagnostics Status and Prospect (2013-2025)
1.4.3 Europe Alzheimer’s Disease Therapeutics and Diagnostics Status and Prospect (2013-2025)
1.4.4 China Alzheimer’s Disease Therapeutics and Diagnostics Status and Prospect (2013-2025)
1.4.5 Japan Alzheimer’s Disease Therapeutics and Diagnostics Status and Prospect (2013-2025)
1.4.6 Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Status and Prospect (2013-2025)
1.4.7 India Alzheimer’s Disease Therapeutics and Diagnostics Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Alzheimer’s Disease Therapeutics and Diagnostics (2013-2025)
1.5.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2025)
1.5.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2013-2025)

2 Global Alzheimer’s Disease Therapeutics and Diagnostics Competition by Players/Suppliers, Type and Application
2.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Competition by Players/Suppliers
2.1.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Alzheimer’s Disease Therapeutics and Diagnostics (Volume and Value) by Type
2.2.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales and Market Share by Type (2013-2018)
2.2.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Market Share by Type (2013-2018)
2.3 Global Alzheimer’s Disease Therapeutics and Diagnostics (Volume and Value) by Region
2.3.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales and Market Share by Region (2013-2018)
2.3.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Market Share by Region (2013-2018)
2.4 Global Alzheimer’s Disease Therapeutics and Diagnostics (Volume) by Application

3 United States Alzheimer’s Disease Therapeutics and Diagnostics (Volume, Value and Sales Price)
3.1 United States Alzheimer’s Disease Therapeutics and Diagnostics Sales and Value (2013-2018)
3.1.1 United States Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
3.1.2 United States Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
3.1.3 United States Alzheimer’s Disease Therapeutics and Diagnostics Sales Price Trend (2013-2018)
3.2 United States Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Players (2013-2018)
3.3 United States Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Type (2013-2018)
3.4 United States Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Application (2013-2018)

4 Europe Alzheimer’s Disease Therapeutics and Diagnostics (Volume, Value and Sales Price)
4.1 Europe Alzheimer’s Disease Therapeutics and Diagnostics Sales and Value (2013-2018)
4.1.1 Europe Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
4.1.2 Europe Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
4.1.3 Europe Alzheimer’s Disease Therapeutics and Diagnostics Sales Price Trend (2013-2018)
4.2 Europe Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Application (2013-2018)

5 China Alzheimer’s Disease Therapeutics and Diagnostics (Volume, Value and Sales Price)
5.1 China Alzheimer’s Disease Therapeutics and Diagnostics Sales and Value (2013-2018)
5.1.1 China Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
5.1.2 China Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
5.1.3 China Alzheimer’s Disease Therapeutics and Diagnostics Sales Price Trend (2013-2018)
5.2 China Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Players (2013-2018)
5.3 China Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Type (2013-2018)
5.4 China Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Application (2013-2018)

6 Japan Alzheimer’s Disease Therapeutics and Diagnostics (Volume, Value and Sales Price)
6.1 Japan Alzheimer’s Disease Therapeutics and Diagnostics Sales and Value (2013-2018)
6.1.1 Japan Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
6.1.2 Japan Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
6.1.3 Japan Alzheimer’s Disease Therapeutics and Diagnostics Sales Price Trend (2013-2018)
6.2 Japan Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics (Volume, Value and Sales Price)
7.1 Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Sales and Value (2013-2018)
7.1.1 Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Sales Price Trend (2013-2018)
7.2 Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Application (2013-2018)

8 India Alzheimer’s Disease Therapeutics and Diagnostics (Volume, Value and Sales Price)
8.1 India Alzheimer’s Disease Therapeutics and Diagnostics Sales and Value (2013-2018)
8.1.1 India Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
8.1.2 India Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
8.1.3 India Alzheimer’s Disease Therapeutics and Diagnostics Sales Price Trend (2013-2018)
8.2 India Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Players (2013-2018)
8.3 India Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Type (2013-2018)
8.4 India Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Application (2013-2018)

9 Global Alzheimer’s Disease Therapeutics and Diagnostics Players/Suppliers Profiles and Sales Data
9.1 Namenda
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Alzheimer’s Disease Therapeutics and Diagnostics Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Namenda Alzheimer’s Disease Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Aricept
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Alzheimer’s Disease Therapeutics and Diagnostics Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Aricept Alzheimer’s Disease Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Exelon
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Alzheimer’s Disease Therapeutics and Diagnostics Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Exelon Alzheimer’s Disease Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Solanezumab
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Alzheimer’s Disease Therapeutics and Diagnostics Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Solanezumab Alzheimer’s Disease Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Gantenerumab
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Alzheimer’s Disease Therapeutics and Diagnostics Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Gantenerumab Alzheimer’s Disease Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Verubecestat
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Alzheimer’s Disease Therapeutics and Diagnostics Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Verubecestat Alzheimer’s Disease Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Pfizer
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Alzheimer’s Disease Therapeutics and Diagnostics Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Pfizer Alzheimer’s Disease Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Eisai
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Alzheimer’s Disease Therapeutics and Diagnostics Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Eisai Alzheimer’s Disease Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Actavis
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Alzheimer’s Disease Therapeutics and Diagnostics Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Actavis Alzheimer’s Disease Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 Lundbeck
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Alzheimer’s Disease Therapeutics and Diagnostics Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Lundbeck Alzheimer’s Disease Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview
9.11 Daiichi Sankyo
9.12 Novartis
9.13 TauRx

10 Alzheimer’s Disease Therapeutics and Diagnostics Maufacturing Cost Analysis
10.1 Alzheimer’s Disease Therapeutics and Diagnostics Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Alzheimer’s Disease Therapeutics and Diagnostics
10.3 Manufacturing Process Analysis of Alzheimer’s Disease Therapeutics and Diagnostics

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Alzheimer’s Disease Therapeutics and Diagnostics Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Alzheimer’s Disease Therapeutics and Diagnostics Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast (2018-2025)
14.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Alzheimer’s Disease Therapeutics and Diagnostics Price and Trend Forecast (2018-2025)
14.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Forecast by Type (2018-2025)
14.3.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Forecast by Type (2018-2025)
14.3.3 Global Alzheimer’s Disease Therapeutics and Diagnostics Price Forecast by Type (2018-2025)
14.4 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Alzheimer's Disease Therapeutics and Diagnostics
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Comparison (K Units) by Type (2013-2025)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type (Product Category) in 2017
Figure Biomarkers Product Picture
Figure Cholinesterase inhibitors Product Picture
Figure NMDA receptor antagonists Product Picture
Figure Brain imaging Product Picture
Figure Blood tests Product Picture
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Comparison (K Units) by Application (2013-2025)
Figure Global Sales Market Share of Alzheimer's Disease Therapeutics and Diagnostics by Application in 2017
Figure Drugs Market Examples
Table Key Downstream Customer in Drugs Market
Figure Diagnostics Market Examples
Table Key Downstream Customer in Diagnostics Market
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Market Size (Million USD) by Regions (2013-2025)
Figure United States Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) (2013-2018)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Alzheimer's Disease Therapeutics and Diagnostics Sales Share by Players/Suppliers
Figure 2017 Alzheimer's Disease Therapeutics and Diagnostics Sales Share by Players/Suppliers
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share by Players
Table 2017 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share by Players
Table Global Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units) and Market Share by Type (2013-2018)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Sales Share (K Units) by Type (2013-2018)
Figure Sales Market Share of Alzheimer's Disease Therapeutics and Diagnostics by Type (2013-2018)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Growth Rate by Type (2013-2018)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Alzheimer's Disease Therapeutics and Diagnostics by Type (2013-2018)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Growth Rate by Type (2013-2018)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Sales Share by Region (2013-2018)
Figure Sales Market Share of Alzheimer's Disease Therapeutics and Diagnostics by Region (2013-2018)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Growth Rate by Region in 2017
Table Global Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Alzheimer's Disease Therapeutics and Diagnostics by Region (2013-2018)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Growth Rate by Region in 2017
Table Global Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Alzheimer's Disease Therapeutics and Diagnostics by Region (2013-2018)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Region in 2017
Table Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Alzheimer's Disease Therapeutics and Diagnostics by Application (2013-2018)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Market Share by Application (2013-2018)
Figure United States Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units) and Growth Rate (2013-2018)
Figure United States Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Alzheimer's Disease Therapeutics and Diagnostics Sales Price (USD/Unit) Trend (2013-2018)
Table United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Players (2013-2018)
Table United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players (2013-2018)
Figure United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players in 2017
Table United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Type (2013-2018)
Table United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type (2013-2018)
Figure United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type in 2017
Table United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Application (2013-2018)
Table United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application (2013-2018)
Figure United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application in 2017
Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Price (USD/Unit) Trend (2013-2018)
Table Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Players (2013-2018)
Table Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players (2013-2018)
Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players in 2017
Table Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Type (2013-2018)
Table Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type (2013-2018)
Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type in 2017
Table Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Application (2013-2018)
Table Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application (2013-2018)
Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application in 2017
Figure China Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units) and Growth Rate (2013-2018)
Figure China Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Alzheimer's Disease Therapeutics and Diagnostics Sales Price (USD/Unit) Trend (2013-2018)
Table China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Players (2013-2018)
Table China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players (2013-2018)
Figure China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players in 2017
Table China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Type (2013-2018)
Table China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type (2013-2018)
Figure China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type in 2017
Table China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Application (2013-2018)
Table China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application (2013-2018)
Figure China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application in 2017
Figure Japan Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Players (2013-2018)
Table Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players (2013-2018)
Figure Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players in 2017
Table Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Type (2013-2018)
Table Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type (2013-2018)
Figure Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type in 2017
Table Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Application (2013-2018)
Table Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application (2013-2018)
Figure Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application in 2017
Figure Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Players (2013-2018)
Table Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players in 2017
Table Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type in 2017
Table Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Application (2013-2018)
Table Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application in 2017
Figure India Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units) and Growth Rate (2013-2018)
Figure India Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Alzheimer's Disease Therapeutics and Diagnostics Sales Price (USD/Unit) Trend (2013-2018)
Table India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Players (2013-2018)
Table India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players (2013-2018)
Figure India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players in 2017
Table India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Type (2013-2018)
Table India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type (2013-2018)
Figure India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type in 2017
Table India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Application (2013-2018)
Table India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application (2013-2018)
Figure India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application in 2017
Table Namenda Basic Information List
Table Namenda Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Namenda Alzheimer's Disease Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
Figure Namenda Alzheimer's Disease Therapeutics and Diagnostics Sales Global Market Share (2013-2018)
Figure Namenda Alzheimer's Disease Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
Table Aricept Basic Information List
Table Aricept Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Aricept Alzheimer's Disease Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
Figure Aricept Alzheimer's Disease Therapeutics and Diagnostics Sales Global Market Share (2013-2018)
Figure Aricept Alzheimer's Disease Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
Table Exelon Basic Information List
Table Exelon Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Exelon Alzheimer's Disease Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
Figure Exelon Alzheimer's Disease Therapeutics and Diagnostics Sales Global Market Share (2013-2018
Figure Exelon Alzheimer's Disease Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
Table Solanezumab Basic Information List
Table Solanezumab Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Solanezumab Alzheimer's Disease Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
Figure Solanezumab Alzheimer's Disease Therapeutics and Diagnostics Sales Global Market Share (2013-2018)
Figure Solanezumab Alzheimer's Disease Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
Table Gantenerumab Basic Information List
Table Gantenerumab Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Gantenerumab Alzheimer's Disease Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
Figure Gantenerumab Alzheimer's Disease Therapeutics and Diagnostics Sales Global Market Share (2013-2018)
Figure Gantenerumab Alzheimer's Disease Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
Table Verubecestat Basic Information List
Table Verubecestat Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Verubecestat Alzheimer's Disease Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
Figure Verubecestat Alzheimer's Disease Therapeutics and Diagnostics Sales Global Market Share (2013-2018
Figure Verubecestat Alzheimer's Disease Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Alzheimer's Disease Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
Figure Pfizer Alzheimer's Disease Therapeutics and Diagnostics Sales Global Market Share (2013-2018)
Figure Pfizer Alzheimer's Disease Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
Table Eisai Basic Information List
Table Eisai Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eisai Alzheimer's Disease Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
Figure Eisai Alzheimer's Disease Therapeutics and Diagnostics Sales Global Market Share (2013-2018
Figure Eisai Alzheimer's Disease Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
Table Actavis Basic Information List
Table Actavis Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Actavis Alzheimer's Disease Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
Figure Actavis Alzheimer's Disease Therapeutics and Diagnostics Sales Global Market Share (2013-2018)
Figure Actavis Alzheimer's Disease Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
Table Lundbeck Basic Information List
Table Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
Figure Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Sales Global Market Share (2013-2018)
Figure Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
Table Daiichi Sankyo Basic Information List
Table Novartis Basic Information List
Table TauRx Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Alzheimer's Disease Therapeutics and Diagnostics
Figure Manufacturing Process Analysis of Alzheimer's Disease Therapeutics and Diagnostics
Figure Alzheimer's Disease Therapeutics and Diagnostics Industrial Chain Analysis
Table Raw Materials Sources of Alzheimer's Disease Therapeutics and Diagnostics Major Players in 2017
Table Major Buyers of Alzheimer's Disease Therapeutics and Diagnostics
Table Distributors/Traders List
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share Forecast by Regions in 2025
Table Global Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share Forecast by Regions in 2025
Figure United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate Forecast (2018-2025)
Figure China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units) Forecast by Type (2018-2025)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share Forecast by Type (2018-2025)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units) Forecast by Application (2018-2025)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【レポートのキーワード】

アルツハイマー病治療薬・診断薬、バイオマーカー、コリンエステラーゼ阻害剤、NMDA受容体アンタゴニスト、脳イメージング、血液検査、薬市場、診断薬市場

★調査レポート[アルツハイマー病治療薬・診断薬の世界市場:販売動向2018] (コード:QYR80700722)販売に関する免責事項を必ずご確認ください。
★調査レポート[アルツハイマー病治療薬・診断薬の世界市場:販売動向2018]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆